Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

pCXLE-hSK Citations (179)

Plasmid Article: A more efficient method to generate integration-free human iPS cells.
Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka KI, Shibata T, Kunisada T, Takahashi M, Takahashi J, Saji H, Yamanaka S Nat Methods. 2011 Apr 3. ():.
PubMed Journal

Articles Citing pCXLE-hSK

Articles
Conversion of human fibroblasts to angioblast-like progenitor cells. Kurian L, Sancho-Martinez I, Nivet E, Aguirre A, Moon K, Pendaries C, Volle-Challier C, Bono F, Herbert JM, Pulecio J, Xia Y, Li M, Montserrat N, Ruiz S, Dubova I, Rodriguez C, Denli AM, Boscolo FS, Thiagarajan RD, Gage FH, Loring JF, Laurent LC, Izpisua Belmonte JC. Nat Methods. 2013 Jan;10(1):77-83. doi: 10.1038/nmeth.2255. Epub 2012 Dec 2. PubMed
To clone or not to clone? Induced pluripotent stem cells can be generated in bulk culture. Willmann CA, Hemeda H, Pieper LA, Lenz M, Qin J, Joussen S, Sontag S, Wanek P, Denecke B, Schuler HM, Zenke M, Wagner W. PLoS One. 2013 May 29;8(5):e65324. doi: 10.1371/journal.pone.0065324. Print 2013. PubMed
Transcriptome comparison of human neurons generated using induced pluripotent stem cells derived from dental pulp and skin fibroblasts. Chen J, Lin M, Foxe JJ, Pedrosa E, Hrabovsky A, Carroll R, Zheng D, Lachman HM. PLoS One. 2013 Oct 3;8(10):e75682. doi: 10.1371/journal.pone.0075682. eCollection 2013. PubMed
A systematic evaluation of integration free reprogramming methods for deriving clinically relevant patient specific induced pluripotent stem (iPS) cells. Goh PA, Caxaria S, Casper C, Rosales C, Warner TT, Coffey PJ, Nathwani AC. PLoS One. 2013 Nov 26;8(11):e81622. doi: 10.1371/journal.pone.0081622. eCollection 2013. PubMed
Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs. Liu GH, Suzuki K, Li M, Qu J, Montserrat N, Tarantino C, Gu Y, Yi F, Xu X, Zhang W, Ruiz S, Plongthongkum N, Zhang K, Masuda S, Nivet E, Tsunekawa Y, Soligalla RD, Goebl A, Aizawa E, Kim NY, Kim J, Dubova I, Li Y, Ren R, Benner C, del Sol A, Bueren J, Trujillo JP, Surralles J, Cappelli E, Dufour C, Esteban CR, Izpisua Belmonte JC. Nat Commun. 2014 Jul 7;5:4330. doi: 10.1038/ncomms5330. PubMed
Transient p53 suppression increases reprogramming of human fibroblasts without affecting apoptosis and DNA damage. Rasmussen MA, Holst B, Tumer Z, Johnsen MG, Zhou S, Stummann TC, Hyttel P, Clausen C. Stem Cell Reports. 2014 Sep 9;3(3):404-13. doi: 10.1016/j.stemcr.2014.07.006. Epub 2014 Aug 21. PubMed
Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells. Schwarz N, Carr AJ, Lane A, Moeller F, Chen LL, Aguila M, Nommiste B, Muthiah MN, Kanuga N, Wolfrum U, Nagel-Wolfrum K, da Cruz L, Coffey PJ, Cheetham ME, Hardcastle AJ. Hum Mol Genet. 2015 Feb 15;24(4):972-86. doi: 10.1093/hmg/ddu509. Epub 2014 Oct 6. PubMed
Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. McCracken KW, Cata EM, Crawford CM, Sinagoga KL, Schumacher M, Rockich BE, Tsai YH, Mayhew CN, Spence JR, Zavros Y, Wells JM. Nature. 2014 Dec 18;516(7531):400-4. doi: 10.1038/nature13863. Epub 2014 Oct 29. PubMed
Laser-assisted generation of human induced pluripotent stem cells. Liu Y, Wu D, Lao D, Peterson C, Hohenstein Elliott KA, Snyder EY. Curr Protoc Stem Cell Biol. 2014 Nov 3;31:4A.7.1-4A.7.15. doi: 10.1002/9780470151808.sc04a07s31. PubMed
Efficient iPS cell generation from blood using episomes and HDAC inhibitors. Hubbard JJ, Sullivan SK, Mills JA, Hayes BJ, Torok-Storb BJ, Ramakrishnan A. J Vis Exp. 2014 Oct 28;(92):e52009. doi: 10.3791/52009. PubMed
A comparison of non-integrating reprogramming methods. Schlaeger TM, Daheron L, Brickler TR, Entwisle S, Chan K, Cianci A, DeVine A, Ettenger A, Fitzgerald K, Godfrey M, Gupta D, McPherson J, Malwadkar P, Gupta M, Bell B, Doi A, Jung N, Li X, Lynes MS, Brookes E, Cherry AB, Demirbas D, Tsankov AM, Zon LI, Rubin LL, Feinberg AP, Meissner A, Cowan CA, Daley GQ. Nat Biotechnol. 2015 Jan;33(1):58-63. doi: 10.1038/nbt.3070. Epub 2014 Dec 1. PubMed
Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells. Ji H, Zhang X, Oh S, Mayhew CN, Ulm A, Somineni HK, Ericksen M, Wells JM, Khurana Hershey GK. J Allergy Clin Immunol. 2015 Jan;135(1):236-44. doi: 10.1016/j.jaci.2014.08.038. Epub 2014 Oct 14. PubMed
Optimized Generation of Functional Neutrophils and Macrophages from Patient-Specific Induced Pluripotent Stem Cells: Ex Vivo Models of X(0)-Linked, AR22(0)- and AR47(0)- Chronic Granulomatous Diseases. Brault J, Goutagny E, Telugu N, Shao K, Baquie M, Satre V, Coutton C, Grunwald D, Brion JP, Barlogis V, Stephan JL, Plantaz D, Hescheler J, Krause KH, Saric T, Stasia MJ. Biores Open Access. 2014 Dec 1;3(6):311-26. doi: 10.1089/biores.2014.0045. PubMed
A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease. Tidball AM, Bryan MR, Uhouse MA, Kumar KK, Aboud AA, Feist JE, Ess KC, Neely MD, Aschner M, Bowman AB. Hum Mol Genet. 2015 Apr 1;24(7):1929-44. doi: 10.1093/hmg/ddu609. Epub 2014 Dec 8. PubMed
Ultrastructural visualization of the Mesenchymal-to-Epithelial Transition during reprogramming of human fibroblasts to induced pluripotent stem cells. Hoffding MK, Hyttel P. Stem Cell Res. 2015 Jan;14(1):39-53. doi: 10.1016/j.scr.2014.11.003. Epub 2014 Nov 29. PubMed
Modeling Axonal Phenotypes with Human Pluripotent Stem Cells. Denton KR, Xu CC, Li XJ. Methods Mol Biol. 2014 Dec 18. PubMed
Generation of Integration-Free Patient Specific iPS Cells Using Episomal Plasmids Under Feeder Free Conditions. Caxaria S, Arthold S, Nathwani AC, Goh PA. Methods Mol Biol. 2015 Feb 21. PubMed
HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity. Mattis VB, Tom C, Akimov S, Saeedian J, Ostergaard ME, Southwell AL, Doty CN, Ornelas L, Sahabian A, Lenaeus L, Mandefro B, Sareen D, Arjomand J, Hayden MR, Ross CA, Svendsen CN. Hum Mol Genet. 2015 Jun 1;24(11):3257-71. doi: 10.1093/hmg/ddv080. Epub 2015 Mar 3. PubMed
Chromatin fibers are formed by heterogeneous groups of nucleosomes in vivo. Ricci MA, Manzo C, Garcia-Parajo MF, Lakadamyali M, Cosma MP. Cell. 2015 Mar 12;160(6):1145-58. doi: 10.1016/j.cell.2015.01.054. PubMed
KLF4 N-terminal variance modulates induced reprogramming to pluripotency. Kim SI, Oceguera-Yanez F, Hirohata R, Linker S, Okita K, Yamada Y, Yamamoto T, Yamanaka S, Woltjen K. Stem Cell Reports. 2015 Apr 14;4(4):727-43. doi: 10.1016/j.stemcr.2015.02.004. Epub 2015 Mar 12. PubMed

Associated Plasmids

Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1. Romani R, Pirisinu I, Calvitti M, Pallotta MT, Gargaro M, Bistoni G, Vacca C, Di Michele A, Orabona C, Rosati J, Pirro M, Giovagnoli S, Matino D, Prontera P, Rosi G, Grohmann U, Talesa VN, Donti E, Puccetti P, Fallarino F. J Cell Mol Med. 2015 Jul;19(7):1593-605. doi: 10.1111/jcmm.12534. Epub 2015 Mar 17. PubMed
An alternative pluripotent state confers interspecies chimaeric competency. Wu J, Okamura D, Li M, Suzuki K, Luo C, Ma L, He Y, Li Z, Benner C, Tamura I, Krause MN, Nery JR, Du T, Zhang Z, Hishida T, Takahashi Y, Aizawa E, Kim NY, Lajara J, Guillen P, Campistol JM, Esteban CR, Ross PJ, Saghatelian A, Ren B, Ecker JR, Izpisua Belmonte JC. Nature. 2015 May 21;521(7552):316-21. doi: 10.1038/nature14413. Epub 2015 May 6. PubMed
Reprogramming LCLs to iPSCs Results in Recovery of Donor-Specific Gene Expression Signature. Thomas SM, Kagan C, Pavlovic BJ, Burnett J, Patterson K, Pritchard JK, Gilad Y. PLoS Genet. 2015 May 7;11(5):e1005216. doi: 10.1371/journal.pgen.1005216. eCollection 2015 May. PubMed
Differentiation of blood T cells: Reprogramming human induced pluripotent stem cells into neuronal cells. Tsai PH, Chang YC, Lee YY, Ko YL, Yang YH, Lin CF, Chang YL, Yu WC, Shih YH, Chen MT. J Chin Med Assoc. 2015 Jun;78(6):353-9. doi: 10.1016/j.jcma.2015.03.007. Epub 2015 May 26. PubMed
Mitochondrial respiratory dysfunction caused by a heteroplasmic mitochondrial DNA mutation blocks cellular reprogramming. Yokota M, Hatakeyama H, Okabe S, Ono Y, Goto Y. Hum Mol Genet. 2015 Aug 15;24(16):4698-709. doi: 10.1093/hmg/ddv201. Epub 2015 May 29. PubMed
Reprogramming fibroblasts toward cardiomyocytes, neural stem cells and hepatocytes by cell activation and signaling-directed lineage conversion. Zhu S, Wang H, Ding S. Nat Protoc. 2015 Jul;10(7):959-73. doi: 10.1038/nprot.2015.059. Epub 2015 Jun 4. PubMed
A panel of induced pluripotent stem cells from chimpanzees: a resource for comparative functional genomics. Gallego Romero I, Pavlovic BJ, Hernando-Herraez I, Zhou X, Ward MC, Banovich NE, Kagan CL, Burnett JE, Huang CH, Mitrano A, Chavarria CI, Friedrich Ben-Nun I, Li Y, Sabatini K, Leonardo TR, Parast M, Marques-Bonet T, Laurent LC, Loring JF, Gilad Y. Elife. 2015 Jun 23;4:e07103. doi: 10.7554/eLife.07103. PubMed
Transgene-Free Disease-Specific iPSC Generation from Fibroblasts and Peripheral Blood Mononuclear Cells. Fidan K, Ebrahimi A, Caglayan OH, Ozcimen B, Onder TT. Methods Mol Biol. 2016;1353:215-31. doi: 10.1007/7651_2015_278. PubMed
Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids. Meraviglia V, Zanon A, Lavdas AA, Schwienbacher C, Silipigni R, Di Segni M, Chen HS, Pramstaller PP, Hicks AA, Rossini A. J Vis Exp. 2015 Jun 5;(100):e52885. doi: 10.3791/52885. PubMed
MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del. Zhao D, Lin M, Chen J, Pedrosa E, Hrabovsky A, Fourcade HM, Zheng D, Lachman HM. PLoS One. 2015 Jul 14;10(7):e0132387. doi: 10.1371/journal.pone.0132387. eCollection 2015. PubMed
Generation and Characterization of Induced Pluripotent Stem Cells from Patients with mtDNA Mutations. Hamalainen RH, Suomalainen A. Methods Mol Biol. 2016;1353:65-75. doi: 10.1007/7651_2015_258. PubMed
Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNA(Trp). Hatakeyama H, Katayama A, Komaki H, Nishino I, Goto Y. Acta Neuropathol Commun. 2015 Aug 22;3:52. doi: 10.1186/s40478-015-0227-x. PubMed
Generation of Integration-free Human Induced Pluripotent Stem Cells Using Hair-derived Keratinocytes. Hung SS, Pebay A, Wong RC. J Vis Exp. 2015 Aug 20;(102):e53174. doi: 10.3791/53174. PubMed
A Comparative View on Easy to Deploy non-Integrating Methods for Patient-Specific iPSC Production. Manzini S, Viiri LE, Marttila S, Aalto-Setala K. Stem Cell Rev. 2015 Dec;11(6):900-8. doi: 10.1007/s12015-015-9619-3. PubMed
Practical Integration-Free Episomal Methods for Generating Human Induced Pluripotent Stem Cells. Kime C, Rand TA, Ivey KN, Srivastava D, Yamanaka S, Tomoda K. Curr Protoc Hum Genet. 2015 Oct 6;87:21.2.1-21.2.21. doi: 10.1002/0471142905.hg2102s87. PubMed
Human iPS Cell-Derived Neurons Uncover the Impact of Increased Ras Signaling in Costello Syndrome. Rooney GE, Goodwin AF, Depeille P, Sharir A, Schofield CM, Yeh E, Roose JP, Klein OD, Rauen KA, Weiss LA, Ullian EM. J Neurosci. 2016 Jan 6;36(1):142-52. doi: 10.1523/JNEUROSCI.1547-15.2016. PubMed
C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells. Esanov R, Belle KC, van Blitterswijk M, Belzil VV, Rademakers R, Dickson DW, Petrucelli L, Boylan KB, Dykxhoorn DM, Wuu J, Benatar M, Wahlestedt C, Zeier Z. Exp Neurol. 2016 Mar;277:171-7. doi: 10.1016/j.expneurol.2015.12.022. Epub 2015 Dec 31. PubMed
Overcoming Pluripotent Stem Cell Dependence on the Repair of Endogenous DNA Damage. Chlon TM, Ruiz-Torres S, Maag L, Mayhew CN, Wikenheiser-Brokamp KA, Davies SM, Mehta P, Myers KC, Wells JM, Wells SI. Stem Cell Reports. 2016 Jan 12;6(1):44-54. doi: 10.1016/j.stemcr.2015.12.001. PubMed
Genomic Instability Associated with p53 Knockdown in the Generation of Huntington's Disease Human Induced Pluripotent Stem Cells. Tidball AM, Neely MD, Chamberlin R, Aboud AA, Kumar KK, Han B, Bryan MR, Aschner M, Ess KC, Bowman AB. PLoS One. 2016 Mar 16;11(3):e0150372. doi: 10.1371/journal.pone.0150372. eCollection 2016. PubMed
Generation of integration-free induced pluripotent stem cells from a patient with Familial Mediterranean Fever (FMF). Fidan K, Kavaklioglu G, Ebrahimi A, Ozlu C, Ay NZ, Ruacan A, Gul A, Onder TT. Stem Cell Res. 2015 Nov;15(3):694-6. doi: 10.1016/j.scr.2015.10.018. Epub 2015 Nov 2. PubMed
Transcriptional Reactivation of OTX2, RX1 and SIX3 during Reprogramming Contributes to the Generation of RPE Cells from Human iPSCs. Li P, Sun X, Ma Z, Liu Y, Jin Y, Ge R, Hao L, Ma Y, Han S, Sun H, Zhang M, Li R, Li T, Shen L. Int J Biol Sci. 2016 Feb 20;12(5):505-17. doi: 10.7150/ijbs.14212. eCollection 2016. PubMed
Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa. Shinkuma S, Guo Z, Christiano AM. Proc Natl Acad Sci U S A. 2016 May 17;113(20):5676-81. doi: 10.1073/pnas.1512028113. Epub 2016 May 3. PubMed
Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells. Massa MG, Gisevius B, Hirschberg S, Hinz L, Schmidt M, Gold R, Prochnow N, Haghikia A. PLoS One. 2016 May 9;11(5):e0155274. doi: 10.1371/journal.pone.0155274. eCollection 2016. PubMed
Myocardial commitment from human pluripotent stem cells: Rapid production of human heart grafts. Garreta E, de Onate L, Fernandez-Santos ME, Oria R, Tarantino C, Climent AM, Marco A, Samitier M, Martinez E, Valls-Margarit M, Matesanz R, Taylor DA, Fernandez-Aviles F, Izpisua Belmonte JC, Montserrat N. Biomaterials. 2016 Aug;98:64-78. doi: 10.1016/j.biomaterials.2016.04.003. Epub 2016 Apr 26. PubMed
Concurrent progress of reprogramming and gene correction to overcome therapeutic limitation of mutant ALK2-iPSC. Kim BY, Jeong S, Lee SY, Lee SM, Gweon EJ, Ahn H, Kim J, Chung SK. Exp Mol Med. 2016 Jun 3;48(6):e237. doi: 10.1038/emm.2016.43. PubMed
Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a P301L mutation in microtubule-associated protein tau (MAPT). Rasmussen MA, Hjermind LE, Hasholt LF, Waldemar G, Nielsen JE, Clausen C, Hyttel P, Holst B. Stem Cell Res. 2016 Jan;16(1):70-4. doi: 10.1016/j.scr.2015.12.008. Epub 2015 Dec 12. PubMed
Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a R406W mutation in microtubule-associated protein tau (MAPT). Rasmussen MA, Hjermind LE, Hasholt LF, Waldemar G, Nielsen JE, Clausen C, Hyttel P, Holst B. Stem Cell Res. 2016 Jan;16(1):75-8. doi: 10.1016/j.scr.2015.12.006. Epub 2015 Dec 12. PubMed
Induced pluripotent stem cells (iPSCs) derived from a pre-symptomatic carrier of a R406W mutation in microtubule-associated protein tau (MAPT) causing frontotemporal dementia. Rasmussen MA, Hjermind LE, Hasholt LF, Waldemar G, Nielsen JE, Clausen C, Hyttel P, Holst B. Stem Cell Res. 2016 Jan;16(1):105-9. doi: 10.1016/j.scr.2015.12.012. Epub 2015 Dec 23. PubMed
Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1. Tubsuwan A, Pires C, Rasmussen MA, Schmid B, Nielsen JE, Hjermind LE, Hall V, Nielsen TT, Waldemar G, Hyttel P, Clausen C, Kitiyanant N, Freude KK, Holst B. Stem Cell Res. 2016 Jan;16(1):110-2. doi: 10.1016/j.scr.2015.12.015. Epub 2015 Dec 28. PubMed
Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H271. Marthaler AG, Tubsuwan A, Schmid B, Poulsen UB, Hyttel P, Nielsen JE, Nielsen TT, Holst B. Stem Cell Res. 2016 Jan;16(1):159-61. doi: 10.1016/j.scr.2015.12.027. Epub 2016 Jan 3. PubMed
Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H196. Marthaler AG, Schmid B, Tubsuwan A, Poulsen UB, Engelbrecht AF, Mau-Holzmann UA, Hyttel P, Nielsen JE, Nielsen TT, Holst B. Stem Cell Res. 2016 Jan;16(1):162-5. doi: 10.1016/j.scr.2015.12.031. Epub 2016 Jan 3. PubMed
Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H266. Marthaler AG, Schmid B, Tubsuwan A, Poulsen UB, Hyttel P, Nielsen TT, Nielsen JE, Holst B. Stem Cell Res. 2016 Jan;16(1):166-9. doi: 10.1016/j.scr.2015.12.029. Epub 2016 Jan 3. PubMed
Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H271. Marthaler AG, Schmid B, Tubsuwan A, Poulsen UB, Engelbrecht AF, Mau-Holzmann UA, Hyttel P, Nielsen JE, Nielsen TT, Holst B. Stem Cell Res. 2016 Jan;16(1):180-3. doi: 10.1016/j.scr.2015.12.028. Epub 2016 Jan 3. PubMed
Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H196. Marthaler AG, Schmid B, Tubsuwan A, Poulsen UB, Hyttel P, Nielsen TT, Nielsen JE, Holst B. Stem Cell Res. 2016 Jan;16(1):199-201. doi: 10.1016/j.scr.2015.12.049. Epub 2016 Jan 15. PubMed
Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H266. Marthaler AG, Tubsuwan A, Schmid B, Poulsen UB, Engelbrecht AF, Mau-Holzmann UA, Hyttel P, Nielsen TT, Nielsen JE, Holst B. Stem Cell Res. 2016 Jan;16(1):202-5. doi: 10.1016/j.scr.2015.12.048. Epub 2016 Jan 15. PubMed
Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1. Li T, Pires C, Nielsen TT, Waldemar G, Hjermind LE, Nielsen JE, Dinnyes A, Hyttel P, Freude KK. Stem Cell Res. 2016 Mar;16(2):229-32. doi: 10.1016/j.scr.2016.01.002. Epub 2016 Jan 14. PubMed
Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1. Li T, Pires C, Nielsen TT, Waldemar G, Hjermind LE, Nielsen JE, Dinnyes A, Holst B, Hyttel P, Freude KK. Stem Cell Res. 2016 Mar;16(2):334-7. doi: 10.1016/j.scr.2016.01.001. Epub 2016 Jan 14. PubMed
A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses. Preininger MK, Jha R, Maxwell JT, Wu Q, Singh M, Wang B, Dalal A, Mceachin ZT, Rossoll W, Hales CM, Fischbach PS, Wagner MB, Xu C. Dis Model Mech. 2016 Sep 1;9(9):927-39. doi: 10.1242/dmm.026823. Epub 2016 Aug 4. PubMed
Human Urinary Epithelial Cells as a Source of Engraftable Hepatocyte-Like Cells Using Stem Cell Technology. Sauer V, Tchaikovskaya T, Wang X, Li Y, Zhang W, Tar K, Polgar Z, Ding J, Guha C, Fox IJ, Roy-Chowdhury N, Roy-Chowdhury J. Cell Transplant. 2016 Dec 13;25(12):2221-2243. doi: 10.3727/096368916X692014. Epub 2016 Jun 9. PubMed
Generation of a human induced pluripotent stem cell line via CRISPR-Cas9 mediated integration of a site-specific heterozygous mutation in CHMP2B. Zhang Y, Schmid B, Nielsen TT, Nielsen JE, Clausen C, Hyttel P, Holst B, Freude KK. Stem Cell Res. 2016 Jun 16;17(1):148-150. doi: 10.1016/j.scr.2016.06.004. PubMed
Generation of a human induced pluripotent stem cell line via CRISPR-Cas9 mediated integration of a site-specific homozygous mutation in CHMP2B. Zhang Y, Schmid B, Nielsen TT, Nielsen JE, Clausen C, Hyttel P, Holst B, Freude KK. Stem Cell Res. 2016 Jun 16;17(1):151-153. doi: 10.1016/j.scr.2016.06.005. PubMed
Modeling and correction of structural variations in patient-derived iPSCs using CRISPR/Cas9. Park CY, Sung JJ, Choi SH, Lee DR, Park IH, Kim DW. Nat Protoc. 2016 Nov;11(11):2154-2169. doi: 10.1038/nprot.2016.129. Epub 2016 Oct 6. PubMed
Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 1. Poon A, Li T, Pires C, Nielsen TT, Nielsen JE, Holst B, Dinnyes A, Hyttel P, Freude KK. Stem Cell Res. 2016 Sep 28;17(3):470-473. doi: 10.1016/j.scr.2016.09.016. PubMed
Establishment of SPAST mutant induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia (HSP) patient. Hauser S, Erzler M, Theurer Y, Schuster S, Schule R, Schols L. Stem Cell Res. 2016 Sep 26;17(3):485-488. doi: 10.1016/j.scr.2016.09.022. PubMed
Generation of induced pluripotent stem cells derived from a 77-year-old healthy woman as control for age related diseases. Nimsanor N, Jorring I, Rasmussen MA, Clausen C, Mau-Holzmann UA, Bus C, Hoffmann SA, Gasser T, Kluba T, Holst B, Schmid B. Stem Cell Res. 2016 Sep 28;17(3):550-552. doi: 10.1016/j.scr.2016.09.019. PubMed
Induced pluripotent stem cells (iPSCs) derived from a symptomatic carrier of a S305I mutation in the microtubule-associated protein tau (MAPT)-gene causing frontotemporal dementia. Nimsanor N, Jorring I, Rasmussen MA, Clausen C, Mau-Holzmann UA, Kitiyanant N, Nielsen JE, Nielsen TT, Hyttel P, Holst B, Schmid B. Stem Cell Res. 2016 Oct 20;17(3):564-567. doi: 10.1016/j.scr.2016.10.006. PubMed
Plasmid-Based Generation of Induced Neural Stem Cells from Adult Human Fibroblasts. Capetian P, Azmitia L, Pauly MG, Krajka V, Stengel F, Bernhardi EM, Klett M, Meier B, Seibler P, Stanslowsky N, Moser A, Knopp A, Gillessen-Kaesbach G, Nikkhah G, Wegner F, Dobrossy M, Klein C. Front Cell Neurosci. 2016 Oct 24;10:245. eCollection 2016. PubMed
Integrative transcriptome network analysis of iPSC-derived neurons from schizophrenia and schizoaffective disorder patients with 22q11.2 deletion. Lin M, Pedrosa E, Hrabovsky A, Chen J, Puliafito BR, Gilbert SR, Zheng D, Lachman HM. BMC Syst Biol. 2016 Nov 15;10(1):105. PubMed
Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1. Pires C, Schmid B, Petraeus C, Poon A, Nimsanor N, Nielsen TT, Waldemar G, Hjermind LE, Nielsen JE, Hyttel P, Freude KK. Stem Cell Res. 2016 Sep;17(2):285-288. doi: 10.1016/j.scr.2016.08.002. Epub 2016 Aug 7. PubMed
Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous R486C mutation in CYP7B1 (SPG5). Hoflinger P, Theurer Y, Schule R, Schols L, Hauser S. Stem Cell Res. 2016 Sep;17(2):422-425. doi: 10.1016/j.scr.2016.09.013. Epub 2016 Sep 17. PubMed
Generation of optic atrophy 1 patient-derived induced pluripotent stem cells (iPS-OPA1-BEHR) for disease modeling of complex optic atrophy syndromes (Behr syndrome). Hauser S, Schuster S, Theurer Y, Synofzik M, Schols L. Stem Cell Res. 2016 Sep;17(2):426-429. doi: 10.1016/j.scr.2016.09.012. Epub 2016 Sep 17. PubMed
Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation. Hoflinger P, Hauser S, Theurer Y, Weissenberger S, Wilke C, Schols L. Stem Cell Res. 2016 Sep;17(2):433-436. doi: 10.1016/j.scr.2016.09.010. Epub 2016 Sep 17. PubMed
Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5). Hauser S, Hoflinger P, Theurer Y, Rattay TW, Schols L. Stem Cell Res. 2016 Sep;17(2):437-440. doi: 10.1016/j.scr.2016.09.011. Epub 2016 Sep 18. PubMed
Reductive carboxylation is a major metabolic pathway in the retinal pigment epithelium. Du J, Yanagida A, Knight K, Engel AL, Vo AH, Jankowski C, Sadilek M, Tran VT, Manson MA, Ramakrishnan A, Hurley JB, Chao JR. Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):14710-14715. doi: 10.1073/pnas.1604572113. Epub 2016 Dec 1. PubMed
Generation of an isogenic, gene-corrected iPSC line from a symptomatic 59-year-old female patient with frontotemporal dementia caused by an R406W mutation in the microtubule associated protein tau (MAPT) gene. Nimsanor N, Poulsen U, Rasmussen MA, Clausen C, Mau-Holzmann UA, Nielsen JE, Nielsen TT, Hyttel P, Holst B, Schmid B. Stem Cell Res. 2016 Sep 28;17(3):576-579. doi: 10.1016/j.scr.2016.09.020. PubMed
Generation of an iPSC line from a patient with tyrosine hydroxylase (TH) deficiency: TH-1 iPSC. Jung-Klawitter S, Blau N, Sebe A, Ebersold J, Gohring G, Opladen T. Stem Cell Res. 2016 Oct 26;17(3):580-583. doi: 10.1016/j.scr.2016.10.008. PubMed
Generation of an isogenic, gene-corrected iPSC line from a pre-symptomatic 28-year-old woman with an R406W mutation in the microtubule associated protein tau (MAPT) gene. Nimsanor N, Poulsen U, Rasmussen MA, Clausen C, Mau-Holzmann UA, Nielsen JE, Nielsen TT, Hyttel P, Holst B, Schmid B. Stem Cell Res. 2016 Sep 28;17(3):600-602. doi: 10.1016/j.scr.2016.09.024. PubMed
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis. Ang YS, Rivas RN, Ribeiro AJ, Srivas R, Rivera J, Stone NR, Pratt K, Mohamed TM, Fu JD, Spencer CI, Tippens ND, Li M, Narasimha A, Radzinsky E, Moon-Grady AJ, Yu H, Pruitt BL, Snyder MP, Srivastava D. Cell. 2016 Dec 15;167(7):1734-1749.e22. doi: 10.1016/j.cell.2016.11.033. PubMed
Mitochondrial respiratory dysfunction disturbs neuronal and cardiac lineage commitment of human iPSCs. Yokota M, Hatakeyama H, Ono Y, Kanazawa M, Goto YI. Cell Death Dis. 2017 Jan 12;8(1):e2551. doi: 10.1038/cddis.2016.484. PubMed
Systematic evaluation of markers used for the identification of human induced pluripotent stem cells. Bharathan SP, Manian KV, Aalam SM, Palani D, Deshpande PA, Pratheesh MD, Srivastava A, Velayudhan SR. Biol Open. 2017 Jan 15;6(1):100-108. doi: 10.1242/bio.022111. PubMed
Low dose resveratrol ameliorates mitochondrial respiratory dysfunction and enhances cellular reprogramming. Mizuguchi Y, Hatakeyama H, Sueoka K, Tanaka M, Goto YI. Mitochondrion. 2017 May;34:43-48. doi: 10.1016/j.mito.2016.12.006. Epub 2017 Jan 14. PubMed
Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells. Pei F, Jiang J, Bai S, Cao H, Tian L, Zhao Y, Yang C, Dong H, Ma Y. Stem Cell Res. 2017 Mar;19:94-103. doi: 10.1016/j.scr.2017.01.006. Epub 2017 Jan 12. PubMed
Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells. Trevisan M, Desole G, Costanzi G, Lavezzo E, Palu G, Barzon L. Int J Mol Sci. 2017 Jan 20;18(1). pii: E206. doi: 10.3390/ijms18010206. PubMed
Evaluation of porcine stem cell competence for somatic cell nuclear transfer and production of cloned animals. Secher JO, Liu Y, Petkov S, Luo Y, Li D, Hall VJ, Schmidt M, Callesen H, Bentzon JF, Sorensen CB, Freude KK, Hyttel P. Anim Reprod Sci. 2017 Mar;178:40-49. doi: 10.1016/j.anireprosci.2017.01.007. Epub 2017 Jan 19. PubMed
Interspecies Chimerism with Mammalian Pluripotent Stem Cells. Wu J, Platero-Luengo A, Sakurai M, Sugawara A, Gil MA, Yamauchi T, Suzuki K, Bogliotti YS, Cuello C, Morales Valencia M, Okumura D, Luo J, Vilarino M, Parrilla I, Soto DA, Martinez CA, Hishida T, Sanchez-Bautista S, Martinez-Martinez ML, Wang H, Nohalez A, Aizawa E, Martinez-Redondo P, Ocampo A, Reddy P, Roca J, Maga EA, Esteban CR, Berggren WT, Nunez Delicado E, Lajara J, Guillen I, Guillen P, Campistol JM, Martinez EA, Ross PJ, Izpisua Belmonte JC. Cell. 2017 Jan 26;168(3):473-486.e15. doi: 10.1016/j.cell.2016.12.036. PubMed
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B. Zhang Y, Schmid B, Nikolaisen NK, Rasmussen MA, Aldana BI, Agger M, Calloe K, Stummann TC, Larsen HM, Nielsen TT, Huang J, Xu F, Liu X, Bolund L, Meyer M, Bak LK, Waagepetersen HS, Luo Y, Nielsen JE, Holst B, Clausen C, Hyttel P, Freude KK. Stem Cell Reports. 2017 Mar 14;8(3):648-658. doi: 10.1016/j.stemcr.2017.01.012. Epub 2017 Feb 16. PubMed
Characterization of energy and neurotransmitter metabolism in cortical glutamatergic neurons derived from human induced pluripotent stem cells: A novel approach to study metabolism in human neurons. Aldana BI, Zhang Y, Lihme MF, Bak LK, Nielsen JE, Holst B, Hyttel P, Freude KK, Waagepetersen HS. Neurochem Int. 2017 Jun;106:48-61. doi: 10.1016/j.neuint.2017.02.010. Epub 2017 Feb 24. PubMed
Rescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs. Ramsden CM, Nommiste B, R Lane A, Carr AF, Powner MB, J K Smart M, Chen LL, Muthiah MN, Webster AR, Moore AT, Cheetham ME, da Cruz L, Coffey PJ. Sci Rep. 2017 Mar 3;7(1):51. doi: 10.1038/s41598-017-00142-7. PubMed
EIF4A3 deficient human iPSCs and mouse models demonstrate neural crest defects that underlie Richieri-Costa-Pereira syndrome. Miller EE, Kobayashi GS, Musso CM, Allen M, Ishiy FAA, de Caires LC Jr, Goulart E, Griesi-Oliveira K, Zechi-Ceide RM, Richieri-Costa A, Bertola DR, Passos-Bueno MR, Silver DL. Hum Mol Genet. 2017 Jun 15;26(12):2177-2191. doi: 10.1093/hmg/ddx078. PubMed
Mutations in valosin-containing protein (VCP) decrease ADP/ATP translocation across the mitochondrial membrane and impair energy metabolism in human neurons. Ludtmann MHR, Arber C, Bartolome F, de Vicente M, Preza E, Carro E, Houlden H, Gandhi S, Wray S, Abramov AY. J Biol Chem. 2017 May 26;292(21):8907-8917. doi: 10.1074/jbc.M116.762898. Epub 2017 Mar 30. PubMed
Derivation of Pluripotent Stem Cells with In Vivo Embryonic and Extraembryonic Potency. Yang Y, Liu B, Xu J, Wang J, Wu J, Shi C, Xu Y, Dong J, Wang C, Lai W, Zhu J, Xiong L, Zhu D, Li X, Yang W, Yamauchi T, Sugawara A, Li Z, Sun F, Li X, Li C, He A, Du Y, Wang T, Zhao C, Li H, Chi X, Zhang H, Liu Y, Li C, Duo S, Yin M, Shen H, Belmonte JCI, Deng H. Cell. 2017 Apr 6;169(2):243-257.e25. doi: 10.1016/j.cell.2017.02.005. PubMed
Establishment of MUi009 - A human induced pluripotent stem cells from a 32year old male with homozygous beta degrees -thalassemia coinherited with heterozygous alpha-thalassemia 2. Wongkummool W, Maneepitasut W, Tong-Ngam P, Tangprasittipap A, Munkongdee T, Boonchuay C, Svasti S, Kitiyanant N, Paiboonsukwong K, Fucharoen S, Tubsuwan A. Stem Cell Res. 2017 Apr;20:80-83. doi: 10.1016/j.scr.2017.02.012. Epub 2017 Mar 7. PubMed
Derivation of the human induced pluripotent stem cell line MUi017-A from a patient with homozygous Hemoglobin Constant Spring. Wongkummool W, Maneepitasut W, Munkongdee T, Tong-Ngam P, Tangprasittipap A, Svasti S, Kitiyanant N, Paiboonsukwong K, Fucharoen S, Tubsuwan A. Stem Cell Res. 2017 Apr;20:84-87. doi: 10.1016/j.scr.2017.02.014. Epub 2017 Mar 7. PubMed
Generation of induced pluripotent stem cells from peripheral blood CD34+ hematopoietic progenitors of a 31year old healthy woman. Tangprasittipap A, Jittorntrum B, Wongkummool W, Kitiyanant N, Tubsuwan A. Stem Cell Res. 2017 Apr;20:91-93. doi: 10.1016/j.scr.2017.02.013. Epub 2017 Mar 7. PubMed
Generation of an induced pluripotent stem cell line from chorionic villi of a Turner syndrome spontaneous abortion. Parveen S, Panicker MM, Gupta PK. Stem Cell Res. 2017 Mar;19:12-16. doi: 10.1016/j.scr.2016.12.016. Epub 2016 Dec 13. PubMed
Identification of SSEA-1 expressing enhanced reprogramming (SEER) cells in porcine embryonic fibroblasts. Li D, Secher JO, Juhl M, Mashayekhi K, Nielsen TT, Holst B, Hyttel P, Freude KK, Hall VJ. Cell Cycle. 2017 Jun 3;16(11):1070-1084. doi: 10.1080/15384101.2017.1315490. Epub 2017 Apr 20. PubMed
Mitochondrial replacement in an iPSC model of Leber's hereditary optic neuropathy. Wong RCB, Lim SY, Hung SSC, Jackson S, Khan S, Van Bergen NJ, De Smit E, Liang HH, Kearns LS, Clarke L, Mackey DA, Hewitt AW, Trounce IA, Pebay A. Aging (Albany NY). 2017 Apr;9(4):1341-1350. doi: 10.18632/aging.101231. PubMed
Fluorescent tagged episomals for stoichiometric induced pluripotent stem cell reprogramming. Schmitt CE, Morales BM, Schmitz EMH, Hawkins JS, Lizama CO, Zape JP, Hsiao EC, Zovein AC. Stem Cell Res Ther. 2017 Jun 5;8(1):132. doi: 10.1186/s13287-017-0581-7. PubMed

Associated Plasmids

Differential Sarcomere and Electrophysiological Maturation of Human iPSC-Derived Cardiac Myocytes in Monolayer vs. Aggregation-Based Differentiation Protocols. Jeziorowska D, Fontaine V, Jouve C, Villard E, Dussaud S, Akbar D, Letang V, Cervello P, Itier JM, Pruniaux MP, Hulot JS. Int J Mol Sci. 2017 Jun 1;18(6). pii: E1173. doi: 10.3390/ijms18061173. PubMed
Fetal Therapy Model of Myelomeningocele with Three-Dimensional Skin Using Amniotic Fluid Cell-Derived Induced Pluripotent Stem Cells. Kajiwara K, Tanemoto T, Wada S, Karibe J, Ihara N, Ikemoto Y, Kawasaki T, Oishi Y, Samura O, Okamura K, Takada S, Akutsu H, Sago H, Okamoto A, Umezawa A. Stem Cell Reports. 2017 Jun 6;8(6):1701-1713. doi: 10.1016/j.stemcr.2017.05.013. PubMed
Generation of induced pluripotent stem cell (iPSC) line from a 36-year-old Charcot-Marie-Tooth disease patient with GJB1 mutation (CMTX). Son D, Kang PJ, Yun W, You S. Stem Cell Res. 2017 May;21:9-12. doi: 10.1016/j.scr.2017.03.006. Epub 2017 Mar 15. PubMed
Static Magnetic Field Stimulation Enhances Oligodendrocyte Differentiation and Secretion of Neurotrophic Factors. Prasad A, Teh DBL, Blasiak A, Chai C, Wu Y, Gharibani PM, Yang IH, Phan TT, Lim KL, Yang H, Liu X, All AH. Sci Rep. 2017 Jul 27;7(1):6743. doi: 10.1038/s41598-017-06331-8. PubMed
iPSC-derived neuronal models of PANK2-associated neurodegeneration reveal mitochondrial dysfunction contributing to early disease. Arber C, Angelova PR, Wiethoff S, Tsuchiya Y, Mazzacuva F, Preza E, Bhatia KP, Mills K, Gout I, Abramov AY, Hardy J, Duce JA, Houlden H, Wray S. PLoS One. 2017 Sep 1;12(9):e0184104. doi: 10.1371/journal.pone.0184104. eCollection 2017. PubMed
Generation of an OCT4 reporter human induced pluripotent stem cell line using CRISPR/SpCas9. Balboa D, Weltner J, Novik Y, Eurola S, Wartiovaara K, Otonkoski T. Stem Cell Res. 2017 Aug;23:105-108. doi: 10.1016/j.scr.2017.07.006. Epub 2017 Jul 11. PubMed

Associated Plasmids

Generation of a SOX2 reporter human induced pluripotent stem cell line using CRISPR/SaCas9. Balboa D, Weltner J, Novik Y, Eurola S, Wartiovaara K, Otonkoski T. Stem Cell Res. 2017 Jul;22:16-19. doi: 10.1016/j.scr.2017.05.005. Epub 2017 May 17. PubMed

Associated Plasmids

Sodium channel current loss of function in induced pluripotent stem cell-derived cardiomyocytes from a Brugada syndrome patient. Selga E, Sendfeld F, Martinez-Moreno R, Medine CN, Tura-Ceide O, Wilmut SI, Perez GJ, Scornik FS, Brugada R, Mills NL. J Mol Cell Cardiol. 2018 Jan;114:10-19. doi: 10.1016/j.yjmcc.2017.10.002. Epub 2017 Oct 9. PubMed
Generation of induced pluripotent stem cell (iPSC) line from Charcot-Marie-Tooth disease patient with MPZ mutation (CMT1B). Son D, Kang PJ, Yun W, You S. Stem Cell Res. 2017 Oct;24:5-7. doi: 10.1016/j.scr.2017.08.002. Epub 2017 Aug 5. PubMed
Down Syndrome iPSC-Derived Astrocytes Impair Neuronal Synaptogenesis and the mTOR Pathway In Vitro. Araujo BHS, Kaid C, De Souza JS, Gomes da Silva S, Goulart E, Caires LCJ, Musso CM, Torres LB, Ferrasa A, Herai R, Zatz M, Okamoto OK, Cavalheiro EA. Mol Neurobiol. 2017 Nov 11. pii: 10.1007/s12035-017-0818-6. doi: 10.1007/s12035-017-0818-6. PubMed
TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation. Yahata N, Matsumoto Y, Omi M, Yamamoto N, Hata R. Sci Rep. 2017 Nov 14;7(1):15557. doi: 10.1038/s41598-017-15871-y. PubMed
Establishment and characterization of induced pluripotent stem cells from placental mesenchymal stromal cells. Parveen S. Stem Cell Res. 2018 Mar;27:15-20. doi: 10.1016/j.scr.2017.12.008. Epub 2017 Dec 14. PubMed
Generation of induced pluripotent stem cell line, CSSi002-A (2851), from a patient with juvenile Huntington Disease. Rosati J, Bidollari E, Rotundo G, Ferrari D, Torres B, Bernardini L, Consoli F, De Luca A, Santimone I, Lamorte G, Squitieri F, Vescovi AL. Stem Cell Res. 2018 Mar;27:86-89. doi: 10.1016/j.scr.2018.01.011. Epub 2018 Jan 9. PubMed
Discordant congenital Zika syndrome twins show differential in vitro viral susceptibility of neural progenitor cells. Caires-Junior LC, Goulart E, Melo US, Araujo BHS, Alvizi L, Soares-Schanoski A, de Oliveira DF, Kobayashi GS, Griesi-Oliveira K, Musso CM, Amaral MS, daSilva LF, Astray RM, Suarez-Patino SF, Ventini DC, Gomes da Silva S, Yamamoto GL, Ezquina S, Naslavsky MS, Telles-Silva KA, Weinmann K, van der Linden V, van der Linden H, de Oliveira JRM, Arrais NMR, Melo A, Figueiredo T, Santos S, Meira JGC, Passos SD, de Almeida RP, Bispo AJB, Cavalheiro EA, Kalil J, Cunha-Neto E, Nakaya H, Andreata-Santos R, de Souza Ferreira LC, Verjovski-Almeida S, Ho PL, Passos-Bueno MR, Zatz M. Nat Commun. 2018 Feb 2;9(1):475. doi: 10.1038/s41467-017-02790-9. PubMed
Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-beta and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients. Birnbaum JH, Wanner D, Gietl AF, Saake A, Kundig TM, Hock C, Nitsch RM, Tackenberg C. Stem Cell Res. 2018 Mar;27:121-130. doi: 10.1016/j.scr.2018.01.019. Epub 2018 Jan 28. PubMed
Induced pluripotent stem cells line (UNIPDi003-A) from a patient affected by EEC syndrome carrying the R279H mutation in TP63 gene. Trevisan M, Di Iorio E, Masi G, Riccetti S, Barzon L, Alvisi G, Caenazzo L, Barbaro V, Palu G. Stem Cell Res. 2018 Apr;28:141-144. doi: 10.1016/j.scr.2018.02.008. Epub 2018 Feb 16. PubMed
Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage. Bidollari E, Rotundo G, Ferrari D, Candido O, Bernardini L, Consoli F, De Luca A, Santimone I, Lamorte G, Ilari A, Squitieri F, Vescovi AL, Rosati J. Stem Cell Res. 2018 Apr;28:145-148. doi: 10.1016/j.scr.2018.02.014. Epub 2018 Feb 21. PubMed
Generation of a transgene-free human induced pluripotent stem cell line (UNIPDi001-A) from oral mucosa epithelial stem cells. Alvisi G, Trevisan M, Masi G, Canel V, Caenazzo L, Nespeca P, Barzon L, Di Iorio E, Barbaro V, Palu G. Stem Cell Res. 2018 Apr;28:177-180. doi: 10.1016/j.scr.2018.02.007. Epub 2018 Feb 18. PubMed
Amenable epigenetic traits of dental pulp stem cells underlie high capability of xeno-free episomal reprogramming. Thekkeparambil Chandrabose S, Sriram S, Subramanian S, Cheng S, Ong WK, Rozen S, Kasim NHA, Sugii S. Stem Cell Res Ther. 2018 Mar 20;9(1):68. doi: 10.1186/s13287-018-0796-2. PubMed
Direct evidence of impaired neuronal Na/K-ATPase pump function in alternating hemiplegia of childhood. Simmons CQ, Thompson CH, Cawthon BE, Westlake G, Swoboda KJ, Kiskinis E, Ess KC, George AL Jr. Neurobiol Dis. 2018 Jul;115:29-38. doi: 10.1016/j.nbd.2018.03.009. Epub 2018 Mar 19. PubMed
Mutations in PMPCB Encoding the Catalytic Subunit of the Mitochondrial Presequence Protease Cause Neurodegeneration in Early Childhood. Vogtle FN, Brandl B, Larson A, Pendziwiat M, Friederich MW, White SM, Basinger A, Kucukkose C, Muhle H, Jahn JA, Keminer O, Helbig KL, Delto CF, Myketin L, Mossmann D, Burger N, Miyake N, Burnett A, van Baalen A, Lovell MA, Matsumoto N, Walsh M, Yu HC, Shinde DN, Stephani U, Van Hove JLK, Muller FJ, Helbig I. Am J Hum Genet. 2018 Apr 5;102(4):557-573. doi: 10.1016/j.ajhg.2018.02.014. Epub 2018 Mar 22. PubMed
Comparison of two different culture conditions for derivation of early hiPSC. Hey CAB, Saltokova KB, Bisgaard HC, Moller LB. Cell Biol Int. 2018 Nov;42(11):1467-1473. doi: 10.1002/cbin.10966. Epub 2018 May 10. PubMed
Generation of an integration-free iPSC line (CSCRi005-A) from erythroid progenitor cells of a healthy Indian male individual. Manian KV, Bharathan SP, Maddali M, Srivastava VM, Srivastava A, Velayudhan SR. Stem Cell Res. 2018 May;29:148-151. doi: 10.1016/j.scr.2018.03.020. Epub 2018 Apr 3. PubMed
Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage Juvenile Onset Huntington's Disease. Rotundo G, Bidollari E, Ferrari D, Spasari I, Bernardini L, Consoli F, De Luca A, Santimone I, Lamorte G, Migliore S, Squitieri F, Vescovi AL, Rosati J. Stem Cell Res. 2018 May;29:174-178. doi: 10.1016/j.scr.2018.04.008. Epub 2018 Apr 21. PubMed
Developing two reference control samples for the Indian population. Iyer S, Bhatia P, Rao M, Mukherjee O. Stem Cell Res. 2018 Jul;30:38-42. doi: 10.1016/j.scr.2018.05.001. Epub 2018 May 12. PubMed
High Basal Levels of gammaH2AX in Human Induced Pluripotent Stem Cells Are Linked to Replication-Associated DNA Damage and Repair. Vallabhaneni H, Lynch PJ, Chen G, Park K, Liu Y, Goehe R, Mallon BS, Boehm M, Hursh DA. Stem Cells. 2018 Oct;36(10):1501-1513. doi: 10.1002/stem.2861. Epub 2018 Jul 28. PubMed
Human pluripotent reprogramming with CRISPR activators. Weltner J, Balboa D, Katayama S, Bespalov M, Krjutskov K, Jouhilahti EM, Trokovic R, Kere J, Otonkoski T. Nat Commun. 2018 Jul 6;9(1):2643. doi: 10.1038/s41467-018-05067-x. PubMed

Associated Plasmids

Oral Mucosa-Derived Induced Pluripotent Stem Cells from Patients with Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome. Trevisan M, Alvisi G, Barbaro V, Barzon L, Raffa P, Migliorati A, Desole G, Ruzittu S, Masi G, Di Iorio E, Palu G. Cell Reprogram. 2018 Aug;20(4):215-224. doi: 10.1089/cell.2017.0064. Epub 2018 Jul 10. PubMed
A fast method to reprogram and CRISPR/Cas9 gene editing from erythroblasts. Melo US, de Souza Leite F, Costa S, Rosenberg C, Zatz M. Stem Cell Res. 2018 Aug;31:52-54. doi: 10.1016/j.scr.2018.07.002. Epub 2018 Jul 4. PubMed
GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease. Li L, Tian E, Chen X, Chao J, Klein J, Qu Q, Sun G, Sun G, Huang Y, Warden CD, Ye P, Feng L, Li X, Cui Q, Sultan A, Douvaras P, Fossati V, Sanjana NE, Riggs AD, Shi Y. Cell Stem Cell. 2018 Aug 2;23(2):239-251.e6. doi: 10.1016/j.stem.2018.07.009. PubMed
Directed evolution of CRISPR-Cas9 to increase its specificity. Lee JK, Jeong E, Lee J, Jung M, Shin E, Kim YH, Lee K, Jung I, Kim D, Kim S, Kim JS. Nat Commun. 2018 Aug 6;9(1):3048. doi: 10.1038/s41467-018-05477-x. PubMed

Associated Plasmids

Generation of three spinocerebellar ataxia type-12 patients derived induced pluripotent stem cell lines (IGIBi002-A, IGIBi003-A and IGIBi004-A). Kumar D, Hussain A, Srivastava AK, Mukerji M, Mukherjee O, Faruq M. Stem Cell Res. 2018 Aug;31:216-221. doi: 10.1016/j.scr.2018.08.008. Epub 2018 Aug 14. PubMed
Generation of induced pluripotent stem cells, KCi001-A derived from a Bardet-Biedl syndrome patient compound heterozygous for the BBS1 variants c.1169T>G/c.1135G>C. Hey CAB, Saltokowa KB, Larsen LJ, Tumer Z, Brondum-Nielsen K, Gronskov K, Hjortshoj TD, Moller LB. Stem Cell Res. 2018 Aug;31:235-239. doi: 10.1016/j.scr.2018.08.005. Epub 2018 Aug 10. PubMed
The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans. Xiang X, Piers TM, Wefers B, Zhu K, Mallach A, Brunner B, Kleinberger G, Song W, Colonna M, Herms J, Wurst W, Pocock JM, Haass C. Mol Neurodegener. 2018 Sep 6;13(1):49. doi: 10.1186/s13024-018-0280-6. PubMed
Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies. Rosati J, Ferrari D, Altieri F, Tardivo S, Ricciolini C, Fusilli C, Zalfa C, Profico DC, Pinos F, Bernardini L, Torres B, Manni I, Piaggio G, Binda E, Copetti M, Lamorte G, Mazza T, Carella M, Gelati M, Valente EM, Simeone A, Vescovi AL. Cell Death Dis. 2018 Sep 17;9(10):937. doi: 10.1038/s41419-018-0990-2. PubMed
Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage. Yang G, Hong H, Torres A, Malloy KE, Choudhury GR, Kim J, Daadi MM. Int J Mol Sci. 2018 Sep 17;19(9). pii: ijms19092788. doi: 10.3390/ijms19092788. PubMed
Single-cell RNA-seq reveals dynamic transcriptome profiling in human early neural differentiation. Shang Z, Chen D, Wang Q, Wang S, Deng Q, Wu L, Liu C, Ding X, Wang S, Zhong J, Zhang D, Cai X, Zhu S, Yang H, Liu L, Fink JL, Chen F, Liu X, Gao Z, Xu X. Gigascience. 2018 Nov 1;7(11). pii: 5099469. doi: 10.1093/gigascience/giy117. PubMed
Generation of integration-free iPS cell lines from three sickle cell disease patients from the state of Bahia, Brazil. Martins GLS, Paredes BD, Azevedo CM, Sampaio GLA, Nonaka CKV, Cavalcante BRR, Da Silva KN, Pereira CSE, Soares MBP, Dos Santos RR, Souza BSF. Stem Cell Res. 2018 Dec;33:10-14. doi: 10.1016/j.scr.2018.09.011. Epub 2018 Sep 25. PubMed
Generation of an iPSC line of a patient with Angelman syndrome due to an imprinting defect. Neureiter A, Brandl B, Hiber M, Tandon R, Muller FJ, Steenpass L. Stem Cell Res. 2018 Dec;33:20-24. doi: 10.1016/j.scr.2018.09.015. Epub 2018 Sep 24. PubMed
Generation of induced pluripotent stem cells, KCi002-A derived from a patient with Bardet-Biedl syndrome homozygous for the BBS10 variant c.271insT. Hey CAB, Saltokowa KB, Larsen LJ, Tumer Z, Brondum-Nielsen K, Gronskov K, Hjortshoj TD, Moller LB. Stem Cell Res. 2018 Dec;33:46-50. doi: 10.1016/j.scr.2018.09.013. Epub 2018 Sep 20. PubMed
The 7q11.23 Protein DNAJC30 Interacts with ATP Synthase and Links Mitochondria to Brain Development. Tebbenkamp ATN, Varela L, Choi J, Paredes MI, Giani AM, Song JE, Sestan-Pesa M, Franjic D, Sousa AMM, Liu ZW, Li M, Bichsel C, Koch M, Szigeti-Buck K, Liu F, Li Z, Kawasawa YI, Paspalas CD, Mineur YS, Prontera P, Merla G, Picciotto MR, Arnsten AFT, Horvath TL, Sestan N. Cell. 2018 Nov 1;175(4):1088-1104.e23. doi: 10.1016/j.cell.2018.09.014. PubMed
Generating Loss-of-function iPSC Lines with Combined CRISPR Indel Formation and Reprogramming from Human Fibroblasts. Tidball AM, Swaminathan P, Dang LT, Parent JM. Bio Protoc. 2018 Apr 5;8(7). doi: 10.21769/BioProtoc.2794. PubMed
Generation of two human isogenic iPSC lines from fetal dermal fibroblasts. Tandon R, Brandl B, Baryshnikova N, Landshammer A, Steenpass L, Keminer O, Pless O, Muller FJ. Stem Cell Res. 2018 Dec;33:120-124. doi: 10.1016/j.scr.2018.10.004. Epub 2018 Oct 12. PubMed
Integrated generation of induced pluripotent stem cells in a low-cost device. Lin H, Li Q, Du Q, Wang O, Wang Z, Akert L, Carlson MA, Zhang C, Subramanian A, Zhang C, Lunning M, Li M, Lei Y. Biomaterials. 2019 Jan;189:23-36. doi: 10.1016/j.biomaterials.2018.10.027. Epub 2018 Oct 25. PubMed
Generation of Isogenic Controls for In Vitro Disease Modelling of X-Chromosomal Disorders. Hinz L, Hoekstra SD, Watanabe K, Posthuma D, Heine VM. Stem Cell Rev. 2019 Apr;15(2):276-285. doi: 10.1007/s12015-018-9851-8. PubMed
Cardiac Targeting Peptide, a Novel Cardiac Vector: Studies in Bio-Distribution, Imaging Application, and Mechanism of Transduction. Zahid M, Feldman KS, Garcia-Borrero G, Feinstein TN, Pogodzinski N, Xu X, Yurko R, Czachowski M, Wu YL, Mason NS, Lo CW. Biomolecules. 2018 Nov 14;8(4). pii: biom8040147. doi: 10.3390/biom8040147. PubMed
Optimization of episomal reprogramming for generation of human induced pluripotent stem cells from fibroblasts. Bang JS, Choi NY, Lee M, Ko K, Lee HJ, Park YS, Jeong D, Chung HM, Ko K. Anim Cells Syst (Seoul). 2018 Mar 15;22(2):132-139. doi: 10.1080/19768354.2018.1451367. eCollection 2018. PubMed
Mbd3 Promotes Reprogramming of Primary Human Fibroblasts. Jaffer S, Goh P, Abbasian M, Nathwani AC. Int J Stem Cells. 2018 Nov 30;11(2):235-241. doi: 10.15283/ijsc18036. PubMed
MicroRNA characterization in equine induced pluripotent stem cells. Moro LN, Amin G, Furmento V, Waisman A, Garate X, Neiman G, La Greca A, Santin Velazque NL, Luzzani C, Sevlever GE, Vichera G, Miriuka SG. PLoS One. 2018 Dec 3;13(12):e0207074. doi: 10.1371/journal.pone.0207074. eCollection 2018. PubMed
Unveiling the Role of the Most Impactful Cardiovascular Risk Locus through Haplotype Editing. Lo Sardo V, Chubukov P, Ferguson W, Kumar A, Teng EL, Duran M, Zhang L, Cost G, Engler AJ, Urnov F, Topol EJ, Torkamani A, Baldwin KK. Cell. 2018 Dec 13;175(7):1796-1810.e20. doi: 10.1016/j.cell.2018.11.014. Epub 2018 Dec 6. PubMed
Plasmid-based generation of neural cells from human fibroblasts using non-integrating episomal vectors. Dai SB, Shen T, Zheng TT, Pu JL, Chen XZ. Neural Regen Res. 2019 Mar;14(3):501-505. doi: 10.4103/1673-5374.245476. PubMed
Derivation of iPSC lines from two patients with familial Alzheimer's disease from India. Najar AH, Sneha KM, Ashok A, Babu S, Subramaniam AG, Kannan R, Viswanath B, Purushottam M, Varghese M, Parvez S, Panicker MM, Mukherjee O, Jain S. Stem Cell Res. 2019 Jan;34:101370. doi: 10.1016/j.scr.2018.101370. Epub 2018 Dec 19. PubMed
Generation of seven induced pluripotent stem cell lines from neonates of different ethnic backgrounds. Yin Y, Petersen AJ, Soref C, Richards WD, Ludwig T, Taapken S, Berndt E, Zhang SC, Bhattacharyya A. Stem Cell Res. 2019 Jan;34:101365. doi: 10.1016/j.scr.2018.101365. Epub 2018 Dec 20. PubMed
Generation of two iPSC lines derived from two unrelated patients with Gaucher disease. Nagel M, Reichbauer J, Bohringer J, Schelling Y, Krageloh-Mann I, Schule R, Ulmer U. Stem Cell Res. 2019 Mar;35:101336. doi: 10.1016/j.scr.2018.10.021. Epub 2018 Nov 18. PubMed
DNA damage and transcriptional regulation in iPSC-derived neurons from Ataxia Telangiectasia patients. Corti A, Sota R, Dugo M, Calogero RA, Terragni B, Mantegazza M, Franceschetti S, Restelli M, Gasparini P, Lecis D, Chrzanowska KH, Delia D. Sci Rep. 2019 Jan 24;9(1):651. doi: 10.1038/s41598-018-36912-0. PubMed
SMCHD1 is involved in de novo methylation of the DUX4-encoding D4Z4 macrosatellite. Dion C, Roche S, Laberthonniere C, Broucqsault N, Mariot V, Xue S, Gurzau AD, Nowak A, Gordon CT, Gaillard MC, El-Yazidi C, Thomas M, Schlupp-Robaglia A, Missirian C, Malan V, Ratbi L, Sefiani A, Wollnik B, Binetruy B, Salort Campana E, Attarian S, Bernard R, Nguyen K, Amiel J, Dumonceaux J, Murphy JM, Dejardin J, Blewitt ME, Reversade B, Robin JD, Magdinier F. Nucleic Acids Res. 2019 Apr 8;47(6):2822-2839. doi: 10.1093/nar/gkz005. PubMed
Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes. Kim EY, Barefield DY, Vo AH, Gacita AM, Schuster EJ, Wyatt EJ, Davis JL, Dong B, Sun C, Page P, Dellefave-Castillo L, Demonbreun A, Zhang HF, McNally EM. JCI Insight. 2019 Mar 21;4(6). pii: 122686. doi: 10.1172/jci.insight.122686. eCollection 2019 Mar 21. PubMed
Neutrophils Derived from Genetically Modified Human Induced Pluripotent Stem Cells Circulate and Phagocytose Bacteria In Vivo. Trump LR, Nayak RC, Singh AK, Emberesh S, Wellendorf AM, Lutzko CM, Cancelas JA. Stem Cells Transl Med. 2019 Jun;8(6):557-567. doi: 10.1002/sctm.18-0255. Epub 2019 Feb 21. PubMed
Generation of a human induced pluripotent stem cell line (MUi010-A) from skin fibroblast of patient carrying a c.2104C>T mutation in MYH9 gene. Tangprasittipap A, Jittorntrum B, Kadegasem P, Sasanakul W, Sirachainan N, Kitiyanant N, Hongeng S. Stem Cell Res. 2019 Apr;36:101397. doi: 10.1016/j.scr.2019.101397. Epub 2019 Feb 18. PubMed
Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming. Ebrahimi A, Sevinc K, Gurhan Sevinc G, Cribbs AP, Philpott M, Uyulur F, Morova T, Dunford JE, Goklemez S, Ari S, Oppermann U, Onder TT. Nat Chem Biol. 2019 May;15(5):519-528. doi: 10.1038/s41589-019-0264-z. Epub 2019 Apr 8. PubMed
Evaluation of commonly used ectoderm markers in iPSC trilineage differentiation. Kuang YL, Munoz A, Nalula G, Santostefano KE, Sanghez V, Sanchez G, Terada N, Mattis AN, Iacovino M, Iribarren C, Krauss RM, Medina MW. Stem Cell Res. 2019 May;37:101434. doi: 10.1016/j.scr.2019.101434. Epub 2019 Apr 10. PubMed
Generation of three control iPS cell lines for sickle cell disease studies by reprogramming erythroblasts from individuals without hemoglobinopathies. Paredes BD, Martins GLS, Azevedo CM, Sampaio GLA, Nonaka CKV, Silva KND, Soares MBP, Santos RRD, Souza BSF. Stem Cell Res. 2019 Jul;38:101454. doi: 10.1016/j.scr.2019.101454. Epub 2019 May 4. PubMed
Environmental stress impairs photoreceptor outer segment (POS) phagocytosis and degradation and induces autofluorescent material accumulation in hiPSC-RPE cells. Dalvi S, Galloway CA, Winschel L, Hashim A, Soto C, Tang C, MacDonald LA, Singh R. Cell Death Discov. 2019 May 16;5:96. doi: 10.1038/s41420-019-0171-9. eCollection 2019. PubMed
The Effect of Wnt Pathway Modulators on Human iPSC-Derived Pancreatic Beta Cell Maturation. Vethe H, Ghila L, Berle M, Hoareau L, Haaland OA, Scholz H, Paulo JA, Chera S, Raeder H. Front Endocrinol (Lausanne). 2019 May 8;10:293. doi: 10.3389/fendo.2019.00293. eCollection 2019. PubMed
Feasibility of repairing full-thickness skin defects by iPSC-derived epithelial stem cells seeded on a human acellular amniotic membrane. Zhou H, Wang L, Zhang C, Hu J, Chen J, Du W, Liu F, Ren W, Wang J, Quan R. Stem Cell Res Ther. 2019 May 31;10(1):155. doi: 10.1186/s13287-019-1234-9. PubMed
Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome. Jaffre F, Miller CL, Schanzer A, Evans T, Roberts AE, Hahn A, Kontaridis MI. Circulation. 2019 Jul 16;140(3):207-224. doi: 10.1161/CIRCULATIONAHA.118.037227. Epub 2019 Jun 5. PubMed
Ex Vivo Models of Chronic Granulomatous Disease. Brault J, Vigne B, Stasia MJ. Methods Mol Biol. 2019;1982:587-622. doi: 10.1007/978-1-4939-9424-3_35. PubMed
Pig Chimeric Model with Human Pluripotent Stem Cells. Zhong C, Wu J, Izpisua Belmonte JC. Methods Mol Biol. 2019;2005:101-124. doi: 10.1007/978-1-4939-9524-0_8. PubMed
Embryonic Chimeras with Human Pluripotent Stem Cells. De Los Angeles A, Sakurai M, Wu J. Methods Mol Biol. 2019;2005:125-151. doi: 10.1007/978-1-4939-9524-0_9. PubMed
Parkin Mutation Affects Clock Gene-Dependent Energy Metabolism. Pacelli C, Rotundo G, Lecce L, Menga M, Bidollari E, Scrima R, Cela O, Piccoli C, Cocco T, Vescovi AL, Mazzoccoli G, Rosati J, Capitanio N. Int J Mol Sci. 2019 Jun 5;20(11). pii: ijms20112772. doi: 10.3390/ijms20112772. PubMed
Production and characterization of human induced pluripotent stem cells (iPSC) CSSi007-A (4383) from Joubert Syndrome. Altieri F, D'Anzi A, Martello F, Tardivo S, Spasari I, Ferrari D, Bernardini L, Lamorte G, Mazzoccoli G, Valente EM, Vescovi AL, Rosati J. Stem Cell Res. 2019 Jul;38:101480. doi: 10.1016/j.scr.2019.101480. Epub 2019 Jun 5. PubMed
A six-inhibitor culture medium for improving naive-type pluripotency of porcine pluripotent stem cells. Yuan Y, Park J, Tian Y, Choi J, Pasquariello R, Alexenko AP, Dai A, Behura SK, Roberts RM, Ezashi T. Cell Death Discov. 2019 Jun 17;5:104. doi: 10.1038/s41420-019-0184-4. eCollection 2019. PubMed
Generation of Human PSC-Derived Kidney Organoids with Patterned Nephron Segments and a De Novo Vascular Network. Low JH, Li P, Chew EGY, Zhou B, Suzuki K, Zhang T, Lian MM, Liu M, Aizawa E, Rodriguez Esteban C, Yong KSM, Chen Q, Campistol JM, Fang M, Khor CC, Foo JN, Izpisua Belmonte JC, Xia Y. Cell Stem Cell. 2019 Sep 5;25(3):373-387.e9. doi: 10.1016/j.stem.2019.06.009. Epub 2019 Jul 11. PubMed
Directed differentiation of human induced pluripotent stem cells into mature stratified bladder urothelium. Suzuki K, Koyanagi-Aoi M, Uehara K, Hinata N, Fujisawa M, Aoi T. Sci Rep. 2019 Jul 19;9(1):10506. doi: 10.1038/s41598-019-46848-8. PubMed
Tracking and Predicting Human Somatic Cell Reprogramming Using Nuclear Characteristics. Molugu K, Harkness T, Carlson-Stevermer J, Prestil R, Piscopo NJ, Seymour SK, Knight GT, Ashton RS, Saha K. Biophys J. 2019 Oct 22. pii: S0006-3495(19)30862-8. doi: 10.1016/j.bpj.2019.10.014. PubMed
Generation of human iPS cell line CBTCi001-A from dermal fibroblasts obtained from a healthy donor. Martins GLS, Paredes BD, Sampaio GLA, Nonaka CKV, da Silva KN, Allahdadi KJ, Franca LSA, Soares MBP, Dos Santos RR, Souza BSF. Stem Cell Res. 2019 Dec;41:101630. doi: 10.1016/j.scr.2019.101630. Epub 2019 Oct 21. PubMed
Lymphoblast-derived hiPS cell lines generated from four individuals of a family of genetically unrelated parents and their female monozygotic twins. Bouma MJ, Freund C, IJzerman AP, Boomsma DI, Mummery CL, Raymond K. Stem Cell Res. 2019 Dec;41:101654. doi: 10.1016/j.scr.2019.101654. Epub 2019 Nov 8. PubMed
Generation and characterization of three isogenic induced pluripotent stem cell lines from a patient with Bardet-Biedl syndrome and homozygous for the BBS5 variant. Hey CAB, Larsen LJ, Tumer Z, Brondum-Nielsen K, Gronskov K, Hjortshoj TD, Moller LB. Stem Cell Res. 2019 Dec;41:101594. doi: 10.1016/j.scr.2019.101594. Epub 2019 Nov 4. PubMed
Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications. Liu G, David BT, Trawczynski M, Fessler RG. Stem Cell Rev Rep. 2020 Feb;16(1):3-32. doi: 10.1007/s12015-019-09935-x. PubMed
Generation of eight human induced pluripotent stem cell lines from Parkinson's disease patients carrying familial mutations. Chen M, Maimaitili M, Buchholdt SH, Jensen UB, Febbraro F, Denham M. Stem Cell Res. 2020 Jan;42:101657. doi: 10.1016/j.scr.2019.101657. Epub 2019 Nov 13. PubMed
Reprogrammed Cells Display Distinct Proteomic Signatures Associated with Colony Morphology Variability. Bjorlykke Y, Soviknes AM, Hoareau L, Vethe H, Mathisen AF, Chera S, Vaudel M, Ghila LM, Raeder H. Stem Cells Int. 2019 Nov 18;2019:8036035. doi: 10.1155/2019/8036035. eCollection 2019. PubMed

If you have published an article using this plasmid, please email us at [email protected] to have your article added to this page.